Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 118

1.

Mapping trabecular disconnection "hotspots" in aged human spine and hip.

Aaron JE, Shore PA, Itoda M, Morrison RJ, Hartopp A, Hensor EM, Hordon LD.

Bone. 2015 Sep;78:71-80. doi: 10.1016/j.bone.2015.04.009. Epub 2015 Apr 12.

2.

Preservation of thoracic spine microarchitecture by alendronate: comparison of histology and microCT.

Hordon LD, Itoda M, Shore PA, Shore RC, Heald M, Brown M, Kanis JA, Rodan GA, Aaron JE.

Bone. 2006 Mar;38(3):444-9. Epub 2005 Dec 19.

PMID:
16361121
3.
4.
6.

Effects of zoxazolamine and related centrally acting muscle relaxants on nigrostriatal dopaminergic neurons.

Matthews RT, McMillen BA, Speciale SG, Jarrah H, Shore PA, Sanghera MK, Shepard PD, German DC.

Brain Res Bull. 1984 May;12(5):479-86.

PMID:
6467036
7.
8.

Midbrain dopamine neurons: differential responses to amphetamine isomers.

Browder S, German DC, Shore PA.

Brain Res. 1981 Mar 2;207(2):333-42.

PMID:
7470912
9.

Effects of severe dopamine depletion on dopamine neuronal impulse flow and on tyrosine hydroxylase regulation.

German DC, McMillen BA, Sanghera MK, Saffer SI, Shore PA.

Brain Res Bull. 1981 Feb;6(2):131-4.

PMID:
6110470
10.

Functional and pharmacological significance of brain dopamine and norepinephrine storage pools.

McMillen BA, German DC, Shore PA.

Biochem Pharmacol. 1980 Nov 15;29(22):3045-50. Review. No abstract available.

PMID:
6109535
11.

Pimozide: delayed onset of action at rat striatal pre- and postsynaptic dopamine receptors.

McMillen BA, German DC, Sanghere MK, Warnack W, Shore PA.

J Pharmacol Exp Ther. 1980 Oct;215(1):150-5.

PMID:
6109013
12.

Role of dopamine storage function in the control of rat striatal tyrosine hydroxylase activity.

McMillen BA, Shore PA.

Naunyn Schmiedebergs Arch Pharmacol. 1980 Aug;313(1):39-44.

PMID:
6111026
13.

In vivo monoamine oxidase inhibition by d-amphetamine.

Miller HH, Shore PA, Clarke DE.

Biochem Pharmacol. 1980 May 15;29(10):1347-54. No abstract available.

PMID:
6901611
14.

Effects of chronic desipramine treatment on rat brain noradrenergic responses to alpha-adrenergic drugs.

McMillen BA, Warnack W, German DC, Shore PA.

Eur J Pharmacol. 1980 Feb 8;61(3):239-46.

PMID:
6102522
15.

Monoamine oxidase inhibition by (+)-amphetamine in vivo [proceedings].

Clarke DE, Miller HH, Shore PA.

Br J Pharmacol. 1979 Jul;66(3):435P-436P. No abstract available.

16.

Electrophysiological and biochemical responses of noradrenergic neurons to a non-amphetamine CNS stimulant.

German DC, Sanghera MK, Kiser RS, McMillen BA, Shore PA.

Brain Res. 1979 Apr 27;166(2):331-9.

PMID:
427592
17.

Differences in norepinephrine and dopamine neurotransmitter storage systems.

Sanghera MK, German DC, Kiser RS, Shore PA.

Brain Res Bull. 1979 Mar-Apr;4(2):217-21.

PMID:
223744
18.
19.

Dopaminergic neuronal responses to a non-amphetamine CNS stimulant.

German DC, Harden H, Sanghera MK, Mann D, Kiser RS, Miller HH, Shore PA.

J Neural Transm. 1979;44(1-2):39-49.

PMID:
35584
20.
21.

The reserpine receptor.

Giachetti A, Shore PA.

Life Sci. 1978 Jul 10;23(2):89-92. Review. No abstract available.

PMID:
355757
22.

Distribution of clozapine in the rat: localization in lung.

Gardiner TH, Lewis JM, Shore PA.

J Pharmacol Exp Ther. 1978 Jul;206(1):151-7.

PMID:
660545
24.

The relative functional availability of brain noradrenaline and dopamine storage pools.

McMillen BA, Shore PA.

J Pharm Pharmacol. 1977 Dec;29(12):780-1. No abstract available.

PMID:
22634
25.

Actions of amfonelic acid and other non-amphetamine stimulants on the dopamine neuron.

Shore PA.

J Pharm Pharmacol. 1976 Nov;28(11):855-7. No abstract available.

PMID:
11304
26.

On the mechanism of action of clozapine on the adrenergic neurone.

Dorris RL, Shore PA.

Br J Pharmacol. 1976 Mar;56(3):279-83.

27.
28.

Evidence for a prime role of newly synthesized dopamine in mesolimbic dopamine areas.

Sears ES, Shore PA.

J Pharm Pharmacol. 1975 Sep;27(9):718-20. No abstract available.

PMID:
241823
29.

Mechanisms of storage and release of amines.

Shore PA.

Psychopharmacol Bull. 1975 Apr;11(2):61-2. No abstract available.

PMID:
1135384
30.

On a prime role for newly synthesized dopamine in striatal function.

Shore PA, Dorris RL.

Eur J Pharmacol. 1975 Feb;30(2):315-8.

PMID:
1168577
31.

On the formation of adrenergic amine storage granules as measured by reserpine labeling.

Giachetti A, Shore PA.

Naunyn Schmiedebergs Arch Pharmacol. 1975;288(4):345-54.

PMID:
1178061
32.

Localization and binding of reserpine in the membrane of adrenomedullary amine storage granules.

Giachetti A, Hollenbeck RA, Shore PA.

Naunyn Schmiedebergs Arch Pharmacol. 1974;283(3):263-75. No abstract available.

PMID:
4276756
33.

Interaction of apomorphine, neuroleptics and stimulants with alpha-methyl-m-tyramine, a false dopaminergic transmitter.

Dorris RL, Shore PA.

Biochem Pharmacol. 1974 Feb 15;23(4):867-72. No abstract available.

PMID:
4150986
34.

Differences in amine storage in rat heart and brain.

Enna SJ, Shore PA.

Br J Pharmacol. 1974 Feb;50(2):271-6.

35.

On the nature of the adrenergic neuron extragranular amine binding site.

Enna SJ, Shore PA.

J Neural Transm. 1974;35(2):125-35. No abstract available.

PMID:
4152377
36.

Specific inhibition by -methyltyrosine of amphetamine-induced amine release from brain.

Enna SJ, Dorris RL, Shore PA.

J Pharmacol Exp Ther. 1973 Mar;184(3):576-82. No abstract available.

PMID:
4687221
37.

Evidence for alpha-methyl-m-tyrasmine as a false dopamine-like transmitter.

Dorris RL, Shore PA.

J Pharm Pharmacol. 1972 Jul;24(7):581-3. No abstract available.

PMID:
4403855
38.

Characteristics of storage and release of metaraminol in the rat heart.

Enna SJ, Shore PA.

Biochem Pharmacol. 1972 Jun 1;21(11):1535-42. No abstract available.

PMID:
4646783
39.

Transport and storage of biogenic amines.

Shore PA.

Annu Rev Pharmacol. 1972;12:209-26. Review. No abstract available.

PMID:
4556942
40.

On the mode of amine uptake by the Auerbach plexus of guinea pig small intestine.

Sugrue MF, Shore PA.

Eur J Pharmacol. 1971 Nov-Dec;16(3):347-56. No abstract available.

PMID:
5132562
41.

Regional distribution of persistently bound reserpine in rat brain.

Enna SJ, Shore PA.

Biochem Pharmacol. 1971 Oct;20(10):2910-2. No abstract available.

PMID:
5114522
42.

Amine uptake and storage mechanisms in the corpus striatum of rat and rabbit.

Dorris RL, Shore PA.

J Pharmacol Exp Ther. 1971 Oct;179(1):15-9. No abstract available.

PMID:
4938135
43.

Localization and persistence of metaraminol and -methyl-m-tyramine in rat and rabbit brain.

Dorris RL, Shore PA.

J Pharmacol Exp Ther. 1971 Oct;179(1):10-4. No abstract available.

PMID:
4398538
44.

Failure to affect tissue reserpine concentrations by alteration of adrenergic nerve activity.

Shore PA, Norn S.

Biochem Pharmacol. 1971 Aug;20(8):2133-5. No abstract available.

PMID:
5137978
45.

Amine uptake characteristics of the guinea-pig Auerbach plexus.

Shore PA, Sugrue MF.

Br J Pharmacol. 1971 Aug;42(4):661P-662P. No abstract available.

46.

Further studies on the nature of persistent reserpine binding: evidence for reversible and irreversible binding.

Norn S, Shore PA.

Biochem Pharmacol. 1971 Jun;20(6):1291-5. No abstract available.

PMID:
5118124
47.

Further evidence for a sodium-dependent, optically specific and reserpine-sensitive amine carrier mechanism at the adrenergic neuron.

Sugrue MF, Shore PA.

J Pharmacol Exp Ther. 1971 May;177(2):389-97. No abstract available.

PMID:
5568795
48.

The chemical determination of histamine.

Shore PA.

Methods Biochem Anal. 1971:Suppl:89-97. Review. No abstract available.

PMID:
4934154
49.

Permeability changes induced in the adrenergic neurone by reserpine.

Giachetti A, Shore PA.

Biochem Pharmacol. 1970 May;19(5):1621-6. No abstract available.

PMID:
4935769
50.

The mode of potassium action on the adrenergic neuron amine transport system.

Sugrue MF, Shore PA.

Life Sci. 1969 Dec 1;8(23):1337-41. No abstract available.

PMID:
5360062

Supplemental Content

Loading ...
Support Center